HIGHLIGHTS
- who: Stephanie Kourakis and colleagues from the College of Health and Biomedicine, Victoria University, Melbourne, VIC, Australia have published the research work: Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?, in the Journal: (JOURNAL)
- what: FAEs are currently approved for several indications including psoriasis and RRMS, due to their anti-inflammatory, anti-oxidative and immunomodulatory properties and are investigated for many other indications.
SUMMARY
Dimethyl fumarate (DMF) is a methyl ester of fumaric acid (FA) (i.e., an FA ester (FAE)) registered for the treatment of relapsing forms . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.